PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.
CONCLUSION: SNP rs10945859 in the PARK2 gene could prove useful in predicting the clinical outcome in HCV-infected patients.
PMID: 31208654 [PubMed]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Genetics | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Leprosy | Liver | Liver Cancer | Liver Disease | Study | Typhoid | Urology & Nephrology